DIA 2023: Cal Collins Discusses the Near-Term and Long-Term Future of SMART on FHIR

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Cal Collins, CEO of OpenClinica discusses the near-term and long-term future of SMART on FHIR.

Related Content:

Drug Information Association (DIA) Annual MeetingConferences

DIA 2023 Recap: Q&A with DIA President and Global Chief Executive, Marwan Fathallah

Importance of DCTs Moving Forward

AI and Safety: Finding the Signals that Matter